Group launches seven-figure ad buy boosting vulnerable Democrats on drug prices

Group launches seven-figure ad buy boosting vulnerable Democrats on drug prices
© iStock

A Democratic group is launching $2 million in new digital ads highlighting vulnerable House Democrats’ efforts to lower drug prices. 

The ads from the group Protect Our Care illustrate how Democrats are seeking to keep their momentum going on health care after they focused on the issue in winning back the House last year.

ADVERTISEMENT
The ad buy shows that even as the impeachment inquiry into President TrumpDonald John TrumpTrumps light 97th annual National Christmas Tree Trump to hold campaign rally in Michigan 'Don't mess with Mama': Pelosi's daughter tweets support following press conference comments MORE gains focus, Democrats are still trying to focus on kitchen-table issues like lowering drug prices. 

The new spending will bring the ads to 10 new districts of House freshmen, on top of the 10 districts that were part of an earlier $2 million buy in September focused on pre-existing conditions. 

“Rep. Elissa SlotkinElissa SlotkinIran building hidden arsenal of short-range ballistic missiles in Iraq: report Democrats debate scope of impeachment charges Democrats hit gas on impeachment MORE is standing up to big drug companies,” the narrator in the ad for Slotkin, a Michigan Democrat, states. “She’s fighting to give Medicare the power to negotiate with drug companies for lower prices, reducing your costs by as much as 55 percent.”

“Thank her for leading the fight to lower your drug prices,” it adds.

The 10 new districts in the campaign are those of Democratic Reps. Angie Craig (Minn.), Sharice DavidsSharice DavidsWarren adds Ayanna Pressley as campaign co-chair Overnight Health Care: Democratic group to only endorse AG candidates who back abortion rights | Protect Our Care launches seven-figure ad buy to boost vulnerable Dems | California sues Juul Group launches seven-figure ad buy boosting vulnerable Democrats on drug prices MORE (Kan.), Antonio DelgadoAntonio Ramon DelgadoPowerful House panel to hold 'Medicare for All' hearing next week Overnight Health Care: Democratic group to only endorse AG candidates who back abortion rights | Protect Our Care launches seven-figure ad buy to boost vulnerable Dems | California sues Juul Group launches seven-figure ad buy boosting vulnerable Democrats on drug prices MORE (N.Y.), Lizzie Fletcher (Texas), Jared Golden (Maine), Susie LeeSuzanne (Susie) Kelley LeeMORE (Nev.), Elaine LuriaElaine Goodman LuriaLawmakers honor JFK on 56th anniversary of his death Overnight Health Care: Democratic group to only endorse AG candidates who back abortion rights | Protect Our Care launches seven-figure ad buy to boost vulnerable Dems | California sues Juul Group launches seven-figure ad buy boosting vulnerable Democrats on drug prices MORE (Va.), Lucy McBathLucia (Lucy) Kay McBathLawmakers to watch during Wednesday's impeachment hearing Adam Schiff's star rises with impeachment hearings Georgia congresswoman shares letter to son on the anniversary of his death MORE (Ga.), Chris PappasChristopher (Chris) Charles PappasOvernight Health Care: Democratic group to only endorse AG candidates who back abortion rights | Protect Our Care launches seven-figure ad buy to boost vulnerable Dems | California sues Juul Group launches seven-figure ad buy boosting vulnerable Democrats on drug prices Pelosi-backed group funding ads for vulnerable Democrats amid impeachment inquiry MORE (N.H.) and Susan WildSusan WildOvernight Health Care: Democratic group to only endorse AG candidates who back abortion rights | Protect Our Care launches seven-figure ad buy to boost vulnerable Dems | California sues Juul Group launches seven-figure ad buy boosting vulnerable Democrats on drug prices Overnight Defense: Protests at Trump's NYC Veterans Day speech | House Dems release Pentagon official's deposition transcript | Lawmakers ask Trump to rescind Erdogan invite MORE (Pa.), all of whom face potentially tough reelection races next year. 

House Democrats are planning to vote next month on their signature legislation to lower drug prices, known as H.R. 3, which would empower the secretary of Health and Human Services to negotiate lower prices for up to 250 drugs per year. 

Speaker Nancy PelosiNancy Pelosi 'Don't mess with Mama': Pelosi's daughter tweets support following press conference comments Bloomberg: Trump should be impeached On The Money: Congress races to beat deadline on shutdown | Trump asks Supreme Court to shield financial records from House Democrats | House passes bill to explicitly ban insider trading MORE’s (D-Calif.) office has expressed hope that Trump would back the legislation, given his support for Medicare negotiating drug prices during the 2016 campaign. But Trump backed off that support in office, and the White House has recently criticized Pelosi’s bill, in favor of a somewhat more modest bipartisan measure to lower drug prices in the Senate. 

Republicans warn Pelosi’s bill would hinder the development of new cures. 

“We don’t see that happening,” Protect Our Care Chair Leslie Dach said of GOP support for the bill.

“Every statement from the president is that he opposes it,” he added. 

Campaigning on the issue could still prove effective for Democrats given the priority the public places on lowering drug prices. 

Dach said the ads are to “be sure [House Democrats] get thanked and be sure their constituents know they’re doing it.”